Reata Pharma (RETA)

$172.36 0.00 (0.00%)

16:00 EDT RETA Stock Quote Delayed 30 Minutes

The 7 Most Promising Momentum Stocks to Own Now

By Jeremy Flint, InvestorPlace Contributor Aug 31, 2023

These momentum stock picks are on a run, but it isn't too late to ride the rollercoaster amid broad market volatility.

The 3 Most Promising Pharma Stocks to Own Now

Why Is Reata Pharmaceuticals (RETA) Stock Up 53% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

More Articles

Volume:

Previous Close -

Market Cap 6.37B

PE Ratio -22.59

EPS -7.63

Volume (Avg. Vol.)

Day's Range -

52-Week Range $87.66 - $172.36

Dividend & Yield N/A (N/A)

RETA Stock Predictions, Articles, and Reata Pharma News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer May 10, 2023

It's time for another dive into the biggest pre-market stock movers as we see what shares are on rising and falling on Wednesday!

The 3 Best Growth Stocks to Buy in the Biotech Sector

By Ian Cooper, InvestorPlace Contributor Mar 29, 2023

These three biotech growth stocks are brimming with potential and could offer massive upside for patient investors.

Why Is Reata Pharmaceuticals (RETA) Stock Up 175% Today?

By William White, InvestorPlace Writer Mar 1, 2023

Reata Pharmaceuticals (RETA) stock is rocketing higher on Wednesday following approval from the FDA for one of its drugs.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Mar 1, 2023

It's time to start the day with another breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!

Why Is Reata Pharmaceuticals (RETA) Stock Up 15% Today?

By Josh Enomoto, InvestorPlace Contributor Oct 14, 2022

The FDA will not hold a meeting to review Reata Pharmaceuticals’ therapeutic for a rare disorder yet RETA stock soared. Here’s why.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Dec 9, 2021

Good morning, trader! It's time to kick off another busy day of trading with the biggest pre-market stock movers for Thursday!

Reta shareholders clear buyout deal with Biogen (NASDAQ:RETA)

From Seeking Alpha Sep 21, 2023

Reata Pharmaceuticals (RETA) said that its shareholders approved its previously disclosed acquisition by Biogen (BIIB) at a special meeting on Thursday. Read more here.

Does Biogen's Latest $1.5 Billion-Dollar Move Make It a Buy?

From The Motley Fool Sep 9, 2023

Buying a biotech is a good move, but it might not be enough to entice investors.

Sanofi was mystery bidder in Reata Pharma bidding war - report

From Seeking Alpha Aug 15, 2023

Sanofi (SNY) was the other buyer in the recent bidding war for Reata Pharmaceuticals (RETA), narrowly losing out to Biogen's $7.3 billion offer

Sanofi Was Mystery Bidder That Lost Reata to Biogen

From Bloomberg Aug 15, 2023

Biogen Inc. narrowly beat out Sanofi SA to clinch its $7.3 billion acquisition of Reata Pharmaceuticals, according to people familiar with the matter.

With an Acquisition on the Way, Is Biogen Stock a Buy?

From The Motley Fool Aug 9, 2023

Can the biotech finally get back in the good graces of investors?

3 Top Biotech Stocks Defying the Bear Market

From The Motley Fool Jul 13, 2023

Each has the potential to dramatically outperform the market.

ADVERTISEMENT